New Article in Canadian Liver Journal!
- Sahar Saeed
- Nov 24, 2025
- 1 min read

We are excited to announce our newest publication in the Canadian Liver Journal, entitled "Barriers and facilitators to liver fibrosis screening: Perspectives and practices of Canadian primary care physicians", co-authored by EPIX members Duy Dinh, Jessica Burnside, Sahar Saeed, and an expert multidisciplinary team of nurse practitioners, hepatologists, and primary care physicians.
Metabolic dysfunction–associated steatotic liver disease (MASLD) is highly prevalent, yet primary care physicians (PCPs) face barriers to identifying and referring high-risk individuals. We surveyed Canadian PCPs to identify barriers and facilitators to MASLD-related fibrosis screening. Despite awareness of MASLD risk factors among Canadian PCPs, substantial gaps remain in screening due to limited knowledge, inconsistent tool use, and systemic barriers. These findings highlight the need for a coordinated national strategy to support PCPs in the early identification and referral of patients at risk for MASLD-related fibrosis.




Comments